The 2025-2026 COVID-19 vaccine formulation targets the SARS-CoV-2 sublineage LP.8.1, in line with FDA guidance to more closely match circulating strains 1 Shipping of the LP.8.1-adapted vaccine will ...
Pfizer/BioNTech has initiated its application to the US Food and Drug Administration for full FDA approval of its Covid-19 vaccine for people ages 16 and older, the companies said Friday. This is the ...
The co-founders of vaccine maker BioNTech are stepping down to launch a venture focused on next-generation messenger RNA technology, as the company reported a sharp increase in losses while seeking to ...
The company’s co-founders said they are leaving to start a new mRNA-based company.
BioNTech’s CEO and his fellow co-founder will depart the biopharma by the end of the year to head up a new company focused on ...
Frankfut: The two co-founders and leading executives of Germany's BioNTech will leave the COVID-19 vaccine maker by the end ...
(Reuters) -Pfizer Inc said on Thursday it sold a part of its stake in German drugmaker BioNTech SE, more than five years after both firms formed an alliance that yielded a vaccine to combat the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results